A new study by the National Institutes of Health will explore the ways in which patients with HIV can avoid heart attacks, because one could be especially deadly for someone with the condition, reports the Baltimore Sun.
Cardiovascular disease is one of the most prevalent complications patients get after contracting HIV. To combat it, NIH has organized a long-term study to provide a drug that will treat HIV without causing heart problems. The research will take place at 100 hospitals, academic centers and health facilities around the world.
"When I first started taking care of patients in the 1980s they virtually would all die, but now they're living and getting complications from the disease, the most prominent of which is cardiovascular disease," said Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
To read the full story, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.